Top Banner
Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D. Chief Science Officer, SENS Foundation [email protected]
35

Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Mar 27, 2015

Download

Documents

Jake Andrews
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

Regenerative medicine for aging: are we reaching the knee of the

exponential curve?

Aubrey D.N.J. de Grey, Ph.D.Chief Science Officer, SENS Foundation

[email protected]

http://www.sens.org/

Page 2: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

SENS Foundation

SENS Foundation is a US-registered charity that works to develop, promote

and enable widespread access to regenerative medicine solutions to the

disabilities and diseases of…

AGING

Page 3: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

- Treating aging is just preventative geriatrics

- Old people are people too, deserve health

- Is medicine good only so long as it doesn’t work very well?

- Was the Industrial Revolution a bad thing?

- How much did Jenner/Pasteur understand?

But surely <insert favourite knee-jerk reaction>?

Page 4: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

- Regenerative medicine?

- Aging?

What is…

Page 5: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

Any intervention that seeks to restore the structure of a

tissue/organ to its state before it suffered damage

What is regen med?

Page 6: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

Metabolism

ongoingly causes “damage”.

Damage

eventually causes pathology.

What is aging?

Page 7: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

Pathology

Options for intervention

Gerontology Geriatrics

Metabolism Damage

Page 8: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

Problem: this is metabolism

Page 9: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

Pathology

Options for interventionGerontology Geriatrics

Metabolism Damage

Maintenance

Claim: unlike the others, the maintenance approach may achieve a big extension of human healthy lifespan quite soon.

Page 10: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

This is the damage

No new type of damage confirmed since 1982!

Seven Deadly Things

Cell loss, cell atrophyDivision-obsessed cells (cancer)

Death-resistant cellsMitochondrial mutationsIntracellular junkExtracellular junkExtracellular crosslinks

Page 11: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

Giving the middle-aged 30 years of extra healthy life:

Robust Human Rejuvenation

Damage rising with age It or its effects reversible by

Cell loss, cell atrophy Cell therapy, mainlyDivision-obsessed cells (i.e. cancer)

Telomerase/ALT gene deletion plus periodic stem cell reseeding

Death-resistant cells Suicide genes, immune stimulation

Mitochondrial mutations Allotopic expression of 13 proteins

Intracellular junk Transgenic microbial hydrolases

Extracellular junk Phagocytosis by immune stimulation

Extracellular crosslinks AGE-breaking molecules/enzymes

Page 12: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

Giving the middle-aged 30 years of extra healthy life:

Robust Human RejuvenationSome parts are in clinical trials

Damage rising with age It or its effects reversible by

Cell loss, cell atrophy Cell therapy, mainlyDivision-obsessed cells (i.e. cancer)

Telomerase/ALT gene deletion plus periodic stem cell reseeding

Death-resistant cells Suicide genes, immune stimulation

Mitochondrial mutations Allotopic expression of 13 proteins

Intracellular junk Transgenic microbial hydrolases

Extracellular junk Phagocytosis by immune stimulation

Extracellular crosslinks AGE-breaking molecules/enzymes

Page 13: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

- Clinical endpoints not achieved

- Amyloid is removed

- Tau is not

- No one knows what causes what in AD

- Combination therapies = wings + engine

About those amyloid trials…

Page 14: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

Giving the middle-aged 30 years of extra healthy life:

Robust Human RejuvenationOther parts are making headlines

Damage rising with age It or its effects reversible by

Cell loss, cell atrophy Cell therapy, mainlyDivision-obsessed cells (i.e. cancer)

Telomerase/ALT gene deletion plus periodic stem cell reseeding

Death-resistant cells Suicide genes, immune stimulation

Mitochondrial mutations Allotopic expression of 13 proteins

Intracellular junk Transgenic microbial hydrolases

Extracellular junk Phagocytosis by immune stimulation

Extracellular crosslinks AGE-breaking molecules/enzymes

Page 15: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

Page 16: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

Giving the middle-aged 30 years of extra healthy life:

Robust Human RejuvenationOthers are early but exciting

Damage rising with age It or its effects reversible by

Cell loss, cell atrophy Cell therapy, mainlyDivision-obsessed cells (i.e. cancer)

Telomerase/ALT gene deletion plus periodic stem cell reseeding

Death-resistant cells Suicide genes, immune stimulation

Mitochondrial mutations Allotopic expression of 13 proteins

Intracellular junk Transgenic microbial hydrolases

Extracellular junk Phagocytosis by immune stimulation

Extracellular crosslinks AGE-breaking molecules/enzymes

Page 17: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

Endothelial Cells

Lipid-engorged Lysosome

Foam Cell

Intracellular junk in the artery

Page 18: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

Microbes, like all life, need an ecological niche.

Some get it by brawn (growing very fast)…

…some by brain (living off material that others can't).

Any abundant, energy-rich organic material that is hard to degrade thus provides selective pressure to evolve the machinery to degrade it.

That selective pressure works. Even TNT, PCBs…

Bioremediation: the concept

Page 19: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

Graveyards

are abundant in human remains,

accumulate bones (which are not energy-rich),

do not accumulate oxysterols, tau etc.,

so, should harbour microbes that degrade them…

…whose catabolic enzymes could be therapeutic

Xenocatabolism: the concept

Page 20: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

Environmental decontamination in vivo

Page 21: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

7-ketocholesterol degradationa promising start

Biodegradation 2008; 19(6):807-813

7KC over time in enrichment cultures

days

Page 22: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

Dione metabolite ?M = 398, M13C = 399

Stable isotope labelling and LC/MS reveal 7-ketocholesterol metabolites in the culture supernatant

Culture growing on7-ketocholesterol

Culture growing on13C-labeled 7-ketocholesterol

7-ketocholesterolM = 400, M13C = 401

Hydroxylated dione ?M = 414, M13C = 415

Page 23: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

COX/LAMP1 co-localizes with AO

Acridine Orange EGFP Merge

Page 24: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

pEGFP-COXL1 transfected cells are protected from 7KC-induced toxicity

Mathieu et al., Biotechnol. Bioeng. 2012; 109(9):2409-2415

Page 25: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

Age-related accumulation of fluorescent compounds

in retinal pigment epithelium

neural retina RPE

Page 26: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

Individually corrected for lens absorption

Exc.: 550 nm

MOD FADelori et al., IOVS 42:1855. 2001

Fundus autofluorescence (= RPE lipofuscin) increases with ageFundus autofluorescence (= RPE lipofuscin) increases with age

Page 27: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

A major constitutent of RPE lipofuscin is theA major constitutent of RPE lipofuscin is thefluorescent pigment A2Efluorescent pigment A2E

Eldred and Lasky, 1993Sakai et al., 1996Parish et al., 1998

Page 28: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

pyridinium bisretinoidSakai, Decatur, Nakanishi and Eldred, 1996

A2E

Page 29: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

cationicpolar head

2 hydrophobicside-arms

A2E iso-A2E

Amphiphilic compound

Cl -

Cl -

Page 30: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

Page 31: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

Page 32: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

1) Isolate competent strains; select by starvation.

2) Identify the enzymes (mutagenesis, chemistry, genomics).

3) Make lysosome-targeted transgenes; assay cell toxicity.

4) Assay competence in vitro (more mutagenesis/selection).

5) Construct transgenic mice; assay toxicity in vivo.

6) Assay competence in disease mouse models.

7) Test in humans as for lysosomal storage diseases.

Steps to biomedical application

Page 33: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

- SENSF does research to implement SENS

- But is that enough? Three reasons why not:

- Is SENS complete? (Vijg lab): “prot pleio”

- Is SENS needed? (Reis lab): “weather”

<cue interminable digression re primate CR>

- What will SENS cause? (Hughes group)

A word about “MetaSENS”

Page 34: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

Learn more

Available at Amazon and all good book stores.

Paperback is cheaper, and has an extra chapter!

Visit us on the web athttp://www.sens.org/

Read the (semi-technical) book.

Drop us a line [email protected]

Page 35: Dr Aubrey de Grey Chief Science Officer Regenerative medicine for aging: are we reaching the knee of the exponential curve? Aubrey D.N.J. de Grey, Ph.D.

Dr Aubrey de GreyChief Science Officer

SENS FoundationSENS Foundation works to develop, promote and ensure widespread access to regenerative medicine solutions to the disabilities and diseases of aging.

[email protected]